tiprankstipranks
Trending News
More News >

Izotropic Seeks FDA Feedback for Breast Cancer Imaging Device

Story Highlights
Izotropic Seeks FDA Feedback for Breast Cancer Imaging Device

Don’t Miss TipRanks’ Half-Year Sale

An update from Izotropic ( (TSE:IZO) ) is now available.

Izotropic announced the filing of a pre-submission with the U.S. FDA for the approval of its IzoView Breast CT Imaging System, designed for breast cancer screening in women with dense breast tissue. This advancement responds to a significant need for high-resolution imaging modalities that can improve early detection rates, potentially expanding the market size for IzoView scans by 800%, thus enhancing Izotropic’s market positioning and addressing critical healthcare demands.

More about Izotropic

Izotropic Corporation is a medical device company focused on developing imaging-based products using innovative and emerging technologies for the accurate screening, diagnosis, and treatment of breast cancers.

YTD Price Performance: 150.0%

Average Trading Volume: 76,117

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $6.52M

Find detailed analytics on IZO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1